Weight-loss, diabetes drugs linked to vision problems in small study
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
celebratingthesoaps7h
‘The View’ Sara and Sunny Try to Get Whoopi Goldberg to Reveal a Secret
On a recent episode of The View, Whoopi Goldberg was caught off guard when co-hosts Sara Haines and Sunny Hostin pressed her to reveal a secret.Although Whoopi was ready to talk about Ariana Grande, h ...
Ibj.com7h
Lebanon planning board to review designs for Lilly’s $4.5B foundry at LEAP District
The 200-acre Lilly Medicine Foundry is expected to add 400 full-time jobs for highly skilled workers, including engineers, ...
The wild ways Ozempic is wreaking havoc on couples’ sex lives — or making them hotter
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
What we know about Vitality’s weight-loss jab scheme for workers
Covering some 1.9million people in the UK, private health insurer Vitality has become the country’s first provider to offer ...
Zacks.com on MSN1d
LLY Rises More Than 4% in a Week: How to Play the Stock
Eli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
Ozempic shown to reduce drinking in first trial in alcohol-use disorder
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don't just curb their desire to eat; for some, they also lead them to drink ...